DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Visudyne (Verteporfin) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Visudyne (Verteporfin) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Visudyne side effects in male

Reported by a individual with unspecified qualification from Japan on 2012-07-17

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Retinal Pigment Epithelial Tear, Retinal Haemorrhage, Choroidal Neovascularisation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Avastin
    Start date: 2010-02-18

Avastin
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-01
    End date: 2009-10-01

Avastin
    Start date: 2010-01-14
    End date: 2010-01-14

Lucentis
    Start date: 2009-06-25
    End date: 2009-06-25

Lucentis
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-04-28
    End date: 2009-04-28

Lucentis
    Start date: 2009-12-11
    End date: 2009-12-11

Lucentis
    Start date: 2009-05-28
    End date: 2009-05-28

Visudyne
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-16

Visudyne
    Start date: 2010-01-22
    End date: 2010-01-22

Other drugs received by patient: Theolong; Huscode; Lansoprazole; Diamox; Mucodyne; Catalin; Levofloxacin; Mucosolvan



Possible Visudyne side effects in 82 year old male

Reported by a physician from Japan on 2012-07-17

Patient: 82 year old male, weighing 58.0 kg (127.6 pounds)

Reactions: Retinal Pigment Epithelial Tear, Disease Recurrence, Retinal Haemorrhage, Visual Acuity Reduced, Choroidal Neovascularisation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Avastin
    Indication: AGE-Related Macular Degeneration
    Start date: 2010-01-14
    End date: 2010-01-14

Avastin
    Dosage: 0.05 ml once et
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-01
    End date: 2009-10-01

Lucentis
    Dosage: 0.05 ml once et
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-12-11

Visudyne
    Indication: AGE-Related Macular Degeneration
    Start date: 2010-01-22
    End date: 2010-01-22

Visudyne
    Dosage: 4.8 ml once iv
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-16
    End date: 2009-10-16

Other drugs received by patient: Huscode; Catalin; Theolong; Lansoprazole; Levofloxacin; Mucodyne; Mucosolan; Diamox



Possible Visudyne side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-13

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Retinal Pigment Epithelial Tear, Retinal Haemorrhage, Choroidal Neovascularisation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Avastin
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-01
    End date: 2009-10-01

Avastin
    Start date: 2010-01-14
    End date: 2010-01-14

Avastin
    Start date: 2010-02-18

Lucentis
    Start date: 2009-05-28
    End date: 2009-05-28

Lucentis
    Start date: 2009-12-11
    End date: 2009-12-11

Lucentis
    Start date: 2009-06-25
    End date: 2009-06-25

Lucentis
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-04-28
    End date: 2009-04-28

Visudyne
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-16

Visudyne
    Start date: 2010-01-22
    End date: 2010-01-22



Possible Visudyne side effects in 82 year old male

Reported by a physician from Japan on 2012-06-27

Patient: 82 year old male, weighing 58.0 kg (127.6 pounds)

Reactions: Retinal Pigment Epithelial Tear, Retinal Haemorrhage, Disease Recurrence, Visual Acuity Reduced, Choroidal Neovascularisation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Avastin
    Indication: AGE-Related Macular Degeneration
    Start date: 2010-01-14
    End date: 2010-01-14

Avastin
    Dosage: 0.05 ml once by
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-01
    End date: 2009-10-01

Lucentis
    Dosage: 0.05 ml once by
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-12-11

Visudyne
    Dosage: 4.8 ml once iv
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-16
    End date: 2009-10-16

Visudyne
    Indication: AGE-Related Macular Degeneration
    Start date: 2010-01-22
    End date: 2010-01-22



Possible Visudyne side effects in male

Reported by a individual with unspecified qualification from Japan on 2012-06-26

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Retinal Pigment Epithelial Tear, Retinal Haemorrhage, Choroidal Neovascularisation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Avastin
    Start date: 2010-01-14

Avastin
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-01

Avastin
    Start date: 2010-02-18

Lucentis
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-04-28

Lucentis
    Start date: 2009-06-25

Lucentis
    Start date: 2009-12-11

Lucentis
    Start date: 2009-05-28

Visudyne
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-16

Visudyne
    Start date: 2010-01-22



Possible Visudyne side effects in 82 year old male

Reported by a physician from Japan on 2012-06-15

Patient: 82 year old male, weighing 58.0 kg (127.6 pounds)

Reactions: Retinal Pigment Epithelial Tear, Retinal Haemorrhage, Visual Acuity Reduced, Choroidal Neovascularisation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Avastin
    Indication: AGE-Related Macular Degeneration
    Start date: 2010-01-14
    End date: 2010-01-14

Avastin
    Dosage: 0;05 ml once, ey
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-01
    End date: 2009-10-01

Lucentis
    Dosage: 0.05 ml ince ey
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-12-11

Visudyne
    Dosage: 4.8 ml once, iv
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-10-16
    End date: 2009-10-16

Visudyne
    Indication: AGE-Related Macular Degeneration
    Start date: 2010-01-22
    End date: 2010-01-22

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017